Rab40B is a member of the Rab family, a vast group of small GTPases that play essential roles in intracellular membrane trafficking processes. These GTPases alternate between an active GTP-bound state and an inactive GDP-bound state. The activation and deactivation of Rab proteins are regulated by a set of specific interacting partners such as Guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Rab40B, like other Rabs, is believed to participate in the coordination of specific vesicular transport pathways, ensuring that cellular materials are properly sorted and delivered to their intended destinations within the cell.
Chemicals that inhibit Rab40B predominantly operate by influencing the protein's ability to interact with its partners or by disrupting its essential post-translational modifications. A prominent mechanism employed by some inhibitors in this class is the disruption of the prenylation process, a crucial modification that ensures Rabs anchor to the membrane. Without proper prenylation, Rab40B and similar proteins may lose their membrane association, rendering them dysfunctional. Other inhibitors might affect the GDP/GTP exchange process, thus interfering with the activation and deactivation cycle that is crucial for the Rab's function. Additionally, certain molecules might target the interactions between Rab40B and its specific regulators or effector proteins, effectively stopping the protein from executing its role in vesicular transport. It's worth noting that due to the inherent similarity among Rab family members, achieving specificity within this class of inhibitors is a complex endeavor. Hence, many molecules might have broader effects on several Rab proteins, not just Rab40B. Such non-specific interactions necessitate rigorous testing and validation when attempting to decipher the exact role of Rab40B in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
A geranylgeranyltransferase I inhibitor. By inhibiting geranylgeranylation, it could prevent proper localization of Rabs, potentially affecting Rab40B function. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Alters the activity of cytohesins, which are Guanine nucleotide exchange factors (GEFs) for ARF GTPases. ARFs can coordinate with Rabs; thus, altering ARF activity may indirectly influence Rab40B. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
Targets Rab7 specifically but might have off-target effects on other Rab proteins due to the similarity in the Rab family. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Inhibits farnesyl diphosphate synthase, a key enzyme in the mevalonate pathway, affecting prenylation of small GTPases including Rabs. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Affects ARF GTPases and disrupts the Golgi. By doing so, it can indirectly influence Rab proteins involved in Golgi traffic. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Inhibits HMG-CoA reductase, leading to reduced cholesterol biosynthesis and potentially affecting the mevalonate pathway, impacting prenylation of Rabs. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
A farnesyltransferase inhibitor that can impact the localization and function of farnesylated proteins, including some small GTPases. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Another farnesyltransferase inhibitor that might indirectly impact Rab protein localization and function. | ||||||